4/A//SEC Filing
Irving Bryan 4/A
Accession 0001209191-19-023661
CIK 0001175505other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:43 PM ET
Size
8.2 KB
Accession
0001209191-19-023661
Insider Transaction Report
Form 4/AAmended
Irving Bryan
SVP, Research
Transactions
- Award
Common Stock
2018-05-15+3,750→ 24,750 total - Award
Employee Stock Option (right to buy)
2018-05-15+22,500→ 22,500 totalExercise: $17.75Exp: 2028-05-14→ Common Stock (22,500 underlying)
Footnotes (3)
- [F1]This amendment is being filed to reflect the correct transaction date of May 15, 2018 with respect to the restricted stock and stock option awards initially disclosed in the reporting person's Form 4 filed with the Securities and Exchange Commission on May 14, 2018 (the "Original Form 4"). The Original Form 4 inadvertently reported a transaction date of May 10, 2018 for such awards. Additionally, the exercise price and expiration date of the stock option award disclosed in Table II of the Original Form 4 are amended accordingly based on the correct transaction date of May 15, 2018.
- [F2]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of May 15, 2019, 2020 and 2021, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F3]The shares underlying the option vest at a rate of one forty-eighth (1/48) per month following May 15, 2018, provided the reporting person provides services to the Company through each such date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeother
Related Parties
1- filerCIK 0001715542
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:43 PM ET
- Size
- 8.2 KB